Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Comité de Estándares de la Sociedad Española de Neonatología. Recomendaciones de mínimos para la asistencia al recién nacido sano.
An Esp Pediatr, 55 (2001), pp. 141-145
[2.]
H.C. Kock, J.M. Mercus.
Graves’disease during pregnancy.
Eur J Obstet Gynecol Reprod Bio, 14 (1983), pp. 323-330
[3.]
J.P. Kampmann, K. Johansen, J.M. Hansen, J. Helweg.
Propilthiouracil in human milk. Revision of a dogma.
Lancet, 1 (1980), pp. 736-737
[4.]
Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and others chemicals into human milk.
Pediatrics, 93 (1994), pp. 137-150
[5.]
U.S. Preventive Services Task Force. Screening for phenylketonuria. En Guide to Clinical Preventive Services, 2nd ed. Baltimore: Willians & Wilkins, 1996; 495-502
[6.]
Committee on Genetics, American Academy of Pediatrics. Newborn Screening Fact Sheets.
Pediatrics, 98 (1996), pp. 473-501
[7.]
E. McCabe, L. McCabe, G. Mosher, R. Allen, J. Berman.
Newborn Screening for Phenylketonuria: Predictive Validity as a Function of Age.
Pediatrics, 72 (1983), pp. 390-398
[8.]
A. Ponzone, M. Spada, G. Ferrero, R. Ponzone, S. Ferraris.
Newborn feeding and screening for phenylketonuria.
Acta Paediatr, 88 (1999), pp. 347-348
[9.]
Espada M, Marzana Y, Rodriguez-Alarcón J, Arena J. Phenylketonuria Screening: Effect of early newborn discharge. Book of Abstracs. 4th Meeting of International Society for Neonatal Screening. Stockholm: 13-16 June, 1999; 63
Copyright © 2001. Asociación Española de Pediatría
